Our findings suggest that POSTN may play a crucial role in the initiation, progression, and dissemination of BRCA1-deleted breast cancer, and could serve as a prognostic biomarker in predicting poor survival outcomes in specific subgroups of patients with aggressive and invasive triple-negative breast cancers. This evidence concerns the gene BRCA1 and breast carcinoma.